Thus, these results illustrate that the pentamidine derivative WLC-4059 blocks the interaction between S100A1 and the RAGE V domain significantly by acting as an anti-proliferative agent that could be beneficial for therapeutic approaches for different types of cancers. Here, S100A1 is linked to cancer.